technica.bio
Sitemap · explore everything
Explore the biotech ecosystem
93 companies, 11 technologies and 3 landscapes — fully indexed.
Open the interactive map → State of Biotech 2026 →Landscapes
Technologies & methods
Partial Epigenetic Reprogramming
Longevity · mechanism
Senolytics
Longevity · mechanism
Antibody–Drug Conjugates
Oncology · modality
Targeted Protein Degradation
Oncology · modality
Regulatory T-cell (Treg) Therapy
Immunology · cell therapy
mRNA Therapeutics
Platform · modality
AI-Driven Drug Discovery
Platform · method
AAV Gene Therapy
Modality · delivery
GLP-1 & the Incretin Boom
Metabolic · mechanism
Radioligand Therapy (RLT)
Oncology · modality
CAR-T Cell Therapy
Immuno-oncology · cell therapy
Longevity Pipeline — companies
Altos Labs
Partial epigenetic reprogramming
Calico
Multiple (cellular senescence, neurodeg.)
Retro Biosciences
Reprogramming, autophagy, plasma factors
Unity Biotechnology
Bcl-xL inhibition (senolytic)
BioAge Labs
Apelin/APJ agonism; NLRP3
Loyal
Metabolic / IGF-1 reduction
Life Biosciences
Partial reprogramming (OSK via AAV)
NewLimit
Epigenetic reprogramming (factor discovery)
Rejuvenate Bio
Gene therapy (FGF21, sTGFβR2, klotho); reprogramming
Turn Biotechnologies
mRNA epigenetic reprogramming
Gordian Biotechnology
In vivo pooled gene therapy screening
Shift Bioscience
Reprogramming w/o dedifferentiation
Insilico Medicine
TNIK inhibition (anti-fibrotic / senescence)
Dorian Therapeutics
USP7 inhibition (senolytic)
Genflow Biosciences
SIRT6 (centenarian variant) gene therapy
Elevian
GDF11 supplementation
Cambrian BioPharma
Multiple (mitophagy, senescence, mTOR)
Juvenescence
Multiple aging-focused assets
Fauna Bio
Comparative genomics (hibernators)
ADC Landscape — companies
Daiichi Sankyo
HER2
Gilead
TROP2
AstraZeneca / Daiichi
TROP2
Pfizer (Seagen)
CD30
Pfizer (Seagen)
Nectin-4
Pfizer (Seagen)
Tissue Factor
Roche / Genentech
HER2
Roche
CD79b
AbbVie (ImmunoGen)
FRα
GSK
BCMA
Pfizer
CD33
ADC Therapeutics
CD19
Merck / Kelun-Biotech
TROP2
Merck / Daiichi
B7-H3
Merck / Daiichi
HER3
Genmab (ProfoundBio)
FRα
AstraZeneca (KYM/CSPC)
Claudin 18.2
Bicycle Therapeutics
Nectin-4
BioNTech (DualityBio)
HER2
Mersana
B7-H4
Sutro Biopharma
FRα
BMS / Eisai
FRα
AbbVie
c-Met
Tubulis
Napi2b
Polish Biotech Scene — companies
Ryvu Therapeutics
Small-molecule oncology
Captor Therapeutics
Targeted protein degradation
Molecure
First-in-class small molecules
Celon Pharma
Small molecules & peptides
Pure Biologics
Antibodies & aptamers
Bioceltix
Veterinary stem-cell therapy
Polpharma Biologics
Biosimilar antibodies
Mabion
Biologics CDMO
Scope Fluidics
Molecular diagnostics
Selvita
Discovery CRO
Ardigen
AI drug discovery
ExploRNA Therapeutics
mRNA technology
NanoGroup
Nanoparticle drug delivery
Genomtec
Point-of-care molecular dx
Cardiomatics
AI cardiac diagnostics
Saventic Health
AI diagnostics
PolTREG
Regulatory T-cell therapy
Bioton
Recombinant insulin & biosimilars
Adamed Pharma
Small-molecule R&D
Proteon Pharmaceuticals
Bacteriophage therapeutics
Pharmena
1-MNA small molecule
Genomed
Sequencing & gene therapy
Warsaw Genomics
Genetic testing
MNM Bioscience
Neoantigen cancer immunotherapy
NanoThea
Radiopharma nanoparticles
Synektik
Radiopharmaceuticals + robotics
Braster
Thermography + AI dx
BioCam
Capsule endoscopy + AI
Nestmedic
Telemedical fetal monitoring
StethoMe
AI home stethoscope
Infermedica
AI triage engine
Diagnostyka
Lab diagnostics network
Intelliseq
Genomic bioinformatics
NapiFeryn BioTech
Plant-protein biotech
NanoSanguis
Oxygen-carrier therapeutics
Smarter Diagnostics
AI musculoskeletal imaging
Jutro Medical
AI-run primary care
SensDx
Electrochemical biosensors
Milton Essex
AI thermal-imaging dx
Medicalgorithmics
AI cardiac diagnostics
Biomed-Lublin
Vaccines & plasma products
FamiCord (PBKM)
Stem-cell banking & therapy
genXone
NGS sequencing & microbiome
Read-Gene
Cancer genetics & prevention
Urteste
Enzyme-based cancer dx
BrainScan
AI head-CT diagnostics
Imagene.me
AI genome interpretation
Nanores
Nano/micro R&D services
Balton
Interventional medical devices
HiProMine
Insect-protein biotech
◢ Boom-cycle briefing
Get ahead of the next biotech boom.
New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.
Curated biotech intelligence, compiled for orientation — not investment advice. Company stages, deals and figures move fast; verify against ClinicalTrials.gov, company filings and primary sources before acting.